An insight into the biological activity and structure-based drug design attributes of sulfonylpiperazine derivatives

被引:11
作者
Kilbile, Jaydeo T. [1 ]
Tamboli, Yasinalli [2 ]
Gadekar, Suchita S. [1 ]
Islam, Imadul [2 ]
Supuran, Claudiu T. [3 ]
Sapkal, Suryakant B. [1 ]
机构
[1] MGM Univ, Univ Dept Basic & Appl Sci Chem, Aurangabad 431003, India
[2] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr KAIMRC, Minist Natl Guard Hlth Affairs, Riyadh 14811, Saudi Arabia
[3] Univ Florence, NEUROFARBA Dept, Sez Sci Farmaceut & Nutraceut, Via U Schiff 6, I-50019 Florence, Italy
关键词
Sulfonylpiperazines; Biological activities; Sulfonamides; Anticancer; Structure activity relationship (SAR); Piperazine sulfonamides; VITRO ANTIPROLIFERATIVE ACTIVITY; TARGETING TRYPANOSOMA-CRUZI; PIPERAZINE DERIVATIVES; SULFONAMIDE DERIVATIVES; MOLECULAR DOCKING; ANTICANCER ACTIVITIES; PYRIDAZINONE SERIES; COVALENT INHIBITORS; DISCOVERY; POTENT;
D O I
10.1016/j.molstruc.2023.134971
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The development of new, effective drugs containing nitrogen and sulfur heteroatoms is of paramount importance in medicinal chemistry. A versatile and rational approach for drug design is molecular hy-bridization (MH) which involves the combination of two pharmacophore molecules possessing distinct intrinsic activity into a single scaffold for enhancing their therapeutic potential. Sulfonylpiperazine hy-brids emerged as an attractive scaffold because of their usefulness to target multiple disease areas, sim-ple synthetic pathways, low toxicity, and metabolic stability. This review highlights the applications of various sulfonylpiperazine derivatives in a wide range of therapeutic areas. The structure-activity rela-tionship (SAR) aspects have also been discussed. We anticipate that this review will be useful for medic-inal chemists, biochemists, and drug discovery scientists, providing new ideas for the drug design and development of efficacious, selective, and safer drugs against diverse therapeutic areas.(c) 2023 Elsevier B.V. All rights reserved.
引用
收藏
页数:37
相关论文
共 200 条
[1]   Synthesis, antioxidant, enzyme inhibition and DNA binding studies of novel N-benzylated derivatives of sulfonamide [J].
Abbas, Aadil ;
Murtaza, Shahzad ;
Tahir, Muhammad Nawaz ;
Shamim, Saima ;
Sirajuddin, Muhammad ;
Rana, Usman Ali ;
Naseem, Khadija ;
Rafique, Hummera .
JOURNAL OF MOLECULAR STRUCTURE, 2016, 1117 :269-275
[2]   Piperazine sulfonamides as DPP-IV inhibitors: Synthesis, induced-fit docking and in vitro biological evaluation [J].
Abu Khalaf, Reema ;
Alwarafi, Ebtisam ;
Sabbah, Dima .
ACTA PHARMACEUTICA, 2021, 71 (04) :631-643
[3]  
Agarwal V., 2011, INDIAN J RHEUMATOL, V6, P69, DOI [10.1016/S0973-3698(11)60035-6, DOI 10.1016/S0973-3698(11)60035-6]
[4]   Resveratrol - A comprehensive review of recent advances in anticancer drug design and development [J].
Ahmadi, Reza ;
Ebrahimzadeh, Mohammad Ali .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 200
[5]  
Ahmed A., 2012, J. Chem. Pharm. Res, V4, P872
[6]   Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase [J].
Akbar, Abdullah ;
McNeil, Nicole M. R. ;
Albert, Marie R. ;
Ta, Viviane ;
Adhikary, Gautam ;
Bourgeois, Karine ;
Eckert, Richard L. ;
Keillor, Jeffiey W. .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (18) :7910-7927
[7]   Synthesis and anti-cancer activities of new sulfonamides 4-substituted-triazolyl nucleosides [J].
Alaoui, Soukaina ;
Dufies, Maeva ;
Driowya, Mohsine ;
Demange, Luc ;
Bougrin, Khalid ;
Robert, Guillaume ;
Auberger, Patrick ;
Pages, Gilles ;
Benhida, Rachid .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (09) :1989-1992
[8]   Type 2 diabetes in the young: The evolving epidemic - The International Diabetes Federation Consensus Workshop [J].
Alberti, G ;
Zimmet, P ;
Shaw, J ;
Bloomgarden, Z ;
Kaufman, F ;
Silink, M .
DIABETES CARE, 2004, 27 (07) :1798-1811
[9]   Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties [J].
Altug, Cevher ;
Gunes, Hanife ;
Nocentini, Alessio ;
Monti, Simona Maria ;
Buonanno, Martina ;
Supuran, Claudiu T. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (04) :1456-1464
[10]   Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: Applying a "divide and conquer" strategy [J].
Amin, EA ;
Welsh, WJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (23) :3849-3855